8.2 Biocompatibility and Host Response

Tissue Response

Inflammatory and Foreign Body Reactions

The moment a biomaterial is implanted, the immune system recognizes it as foreign and launches a coordinated response. This foreign body response (FBR) is one of the most important concepts in biomaterials design because it ultimately determines whether an implant integrates with tissue or gets walled off.

Here's the typical sequence:

1. Injury and blood-material contact. Implantation damages local tissue and ruptures blood vessels. Blood proteins immediately adsorb onto the material surface.
2. Acute inflammation (hours to days). Neutrophils arrive first, attempting to degrade the foreign material through reactive oxygen species and enzymes. Classic signs appear: redness, swelling, heat, and pain.
3. Chronic inflammation (days to weeks). If the material persists, monocytes differentiate into macrophages at the implant site. Macrophages that cannot phagocytose the material fuse into foreign body giant cells (FBGCs), a hallmark of the FBR.
4. Fibrous encapsulation. Fibroblasts deposit excessive extracellular matrix proteins, primarily collagen, forming a dense fibrous capsule around the implant. This capsule can impair nutrient/signal transport and prevent the implant from integrating with surrounding tissue.

The thickness and density of that fibrous capsule is often used as a practical measure of biocompatibility. A thinner, more vascularized capsule generally indicates a milder host response.

Cellular Interactions with Biomaterials

Cells don't actually "see" the bare biomaterial surface. Within seconds of implantation, blood and interstitial proteins adsorb onto the surface, forming a protein layer that mediates all subsequent cell-material interactions.

• Protein adsorption is the first event. The composition, conformation, and orientation of adsorbed proteins (fibronectin, vitronectin, fibrinogen, etc.) dictate which cell receptors can bind and how cells behave.
• Cell adhesion is mediated primarily by integrins, transmembrane receptors on cell surfaces that bind to specific motifs (like the RGD sequence) on adsorbed proteins. Adhesion strength and signaling depend heavily on the biomaterial's surface properties: roughness, hydrophilicity, charge, and topography.
• Surface chemistry and micro/nanotopography can be engineered to preferentially adsorb certain proteins and promote desired cell responses (adhesion, spreading, differentiation) while minimizing inflammatory cell activation.

This is why surface modification is such a major area of biomaterials research. You're not just choosing a bulk material; you're engineering the interface that cells actually interact with.

Blood Interactions

Hemocompatibility and Thrombosis

Any device that contacts blood (stents, mechanical heart valves, ventricular assist devices, dialysis membranes) must be hemocompatible, meaning it functions without triggering harmful blood responses. The primary concern is thrombosis: clot formation on the device surface.

The process follows a predictable cascade:

1. Blood proteins adsorb onto the material surface (fibrinogen is especially important here).
2. Platelets adhere to adsorbed fibrinogen via glycoprotein IIb/IIIa receptors, become activated, and change shape.
3. Activated platelets release signaling molecules (ADP, thromboxane $A_2$) that recruit more platelets.
4. The coagulation cascade is activated (both intrinsic and extrinsic pathways), generating thrombin, which converts fibrinogen to fibrin.
5. A stable thrombus forms on the device surface.

Thrombogenicity refers to a material's tendency to promote this process. A highly thrombogenic surface can cause device occlusion, embolism, or stroke. This is why patients with mechanical heart valves typically require lifelong anticoagulation therapy (e.g., warfarin).

Protein-Material Interactions in Blood

Protein adsorption from blood is more complex than from simple tissue fluid because blood contains thousands of proteins at varying concentrations.

• Albumin (the most abundant plasma protein) adsorbs quickly but tends to be relatively passivating, meaning it doesn't strongly activate platelets or coagulation.
• Fibrinogen adsorbs readily and is a major driver of platelet adhesion and activation.
• Immunoglobulins and complement proteins can trigger immune-mediated responses on the surface.

The Vroman effect describes a key dynamic: proteins don't just adsorb and stay put. Higher-concentration, lower-affinity proteins (like albumin) adsorb first, then are gradually displaced by lower-concentration, higher-affinity proteins (like fibrinogen or high-molecular-weight kininogen). This means the protein layer composition changes over time, and early vs. late surface composition can drive very different biological outcomes.

Understanding the Vroman effect matters for design because the surface you test at 5 minutes may behave differently from the surface at 5 hours.

Adverse Effects

Cytotoxicity and Immunological Responses

Even a material that appears structurally sound can cause harm at the cellular level.

Cytotoxicity refers to a material or its degradation products causing cell death. Sources include:

• Leachable components: unreacted monomers, plasticizers, metal ions, or degradation byproducts that diffuse into surrounding tissue.
• Surface-mediated effects: direct contact between cells and a toxic surface chemistry.
• Cytotoxicity is typically the first screen in biocompatibility testing, assessed through standardized in vitro assays (e.g., ISO 10993-5) using cell viability indicators like MTT or live/dead staining.

Immunogenicity is the ability of a material to provoke a specific immune response. This can involve:

• Innate immunity: macrophage activation, complement activation, and inflammatory cytokine release.
• Adaptive immunity: T-cell and B-cell mediated responses, which can lead to chronic rejection.
• Hypersensitivity reactions: some patients develop allergic responses to specific materials. Nickel hypersensitivity, for example, affects roughly 10-15% of the population and is a real concern for metallic implants containing nickel alloys.

The distinction between cytotoxicity and immunogenicity matters: a material can be non-cytotoxic in a dish but still provoke a strong immune response in vivo, and vice versa. Both must be evaluated.

Microbial Colonization and Device-Related Infections

Device-related infections are among the most serious complications in implant medicine. They can lead to implant failure, revision surgery, sepsis, and in severe cases, death.

The central problem is biofilm formation, which proceeds in stages:

1. Initial attachment. Planktonic (free-floating) bacteria adhere to the implant surface, often within hours of implantation. This is facilitated by the same adsorbed protein layer that mediates host cell adhesion.
2. Proliferation and matrix production. Attached bacteria multiply and secrete an extracellular polymeric substance (EPS), forming a structured community.
3. Mature biofilm. The biofilm becomes a dense, organized structure with channels for nutrient transport. Bacteria within the biofilm can be 100-1,000x more resistant to antibiotics compared to their planktonic counterparts.
4. Dispersal. Fragments of the biofilm can detach and seed new infection sites.

Prevention strategies include:

• Antimicrobial coatings: silver nanoparticles, antibiotic-eluting surfaces, or nitric oxide-releasing materials.
• Anti-adhesive surface modifications: hydrophilic polymer brushes (e.g., PEG coatings) or superhydrophobic textures that resist bacterial attachment.
• Strict surgical asepsis: since most device infections originate during the implantation procedure itself.

The "race for the surface" concept is useful here: host cells and bacteria are competing to colonize the implant surface first. If host cells establish a confluent layer before bacteria attach, infection risk drops significantly. This is why promoting rapid host tissue integration is itself an infection-prevention strategy.